Target intelligence / Profile preview

SINHCAF pseudogene 3 (SINHCAFP3)

Target
SINHCAFP3
Molecular classification
Pseudogene, Other
01

Overview

SINHCAF pseudogene 3 (SINHCAFP3, FAM60DP) is a nonfunctional segment of DNA related by sequence homology to SINHCAF/FAM60A, a subunit of the Sin3a histone deacetylase complex involved in transcriptional regulation and embryonic development[1][3][4]. Pseudogenes such as SINHCAFP3 generally lack protein-coding function due to mutations or truncations resulting in frameshifts or premature stop codons[4]. While pseudogenes may rarely acquire regulatory roles through their RNA transcripts (e.g., as sources of siRNAs or by acting as competing endogenous RNAs), no such biological or disease-related roles have been reported for SINHCAFP3[2][4]. It is not considered a receptor, enzyme, transporter, or other therapeutic target, nor is it used as a biomarker or drug target.

Other names
FAM60DPfamily with sequence similarity 60 member D, pseudogenefamily with sequence similarity 60, member A pseudogeneSINHCAFP3
02

Mechanism of action

Not applicable; no drugs known to act on pseudogenes such as SINHCAFP3.

03

Biological functions

No known direct biological function; pseudogenes may influence gene regulation via RNA interference or generation of siRNAs, but functional roles for SINHCAFP3 specifically are unreported[2][4].
04

Disease associations

None known for SINHCAFP3 itself; SINHCAF/FAM60A (the parent functional gene) is implicated in embryonic development, cell cycle regulation, and is associated with disease traits such as type 2 diabetes[1][3]. There is no evidence SINHCAFP3 plays a direct role in any disease.
05

Safety considerations

None reported; as a pseudogene, SINHCAFP3 is typically nonfunctional and not considered in therapeutic contexts[4].
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on SINHCAF pseudogene 3 (SINHCAFP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SINHCAF pseudogene 3 (SINHCAFP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call